Literature DB >> 12603363

Symptoms of depression and anxiety, and screening for mental disorders in migrainous patients.

F Kowacs1, M P Socal, S C Ziomkowski, V F Borges-Neto, D P Toniolo, C R M Francesconi, M L F Chaves.   

Abstract

The purpose of this clinic-based study was the assessment of symptoms of depression, anxiety, and non-specific psychiatric disorders amongst patients with migraine, compared with healthy subjects and with individuals with a non-neurological chronic disease. A cross-sectional study was carried out in which 178 individuals (migraine 51; psoriasis 35; healthy 92) were submitted to three scales: MADRS (depression), STAI-T (anxiety) and SRQ (screening for mental disorders). The subjects with migraine and psoriasis were from the Out-patient Clinics of Headache and of Dermatology, and the healthy volunteers were persons who were accompanying out-patients in the same hospital. Scores were analysed by manova and by association analysis and logistic regression. Scores of all instruments were higher in the migrainous group, but the univariate analysis of association (using cut-offs) showed significance only for suspicion of mental disorders (SRQ). By logistic regression, variables with strongest association to migraine were gender, education, and SRQ in decreasing order.

Entities:  

Mesh:

Year:  2003        PMID: 12603363     DOI: 10.1046/j.1468-2982.2003.00461.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  4 in total

1.  Prevalence and Odds of Anxiety Disorders and Anxiety Symptoms in Children and Adults with Psoriasis: Systematic Review and Meta-analysis.

Authors:  Isabelle Jalenques; Fabien Bourlot; Elisa Martinez; Bruno Pereira; Michel D'Incan; Sophie Lauron; Fabien Rondepierre
Journal:  Acta Derm Venereol       Date:  2022-08-26       Impact factor: 3.875

Review 2.  The prevalence and odds of depressive symptoms and clinical depression in psoriasis patients: a systematic review and meta-analysis.

Authors:  Emmilia A Dowlatshahi; Marlies Wakkee; Lidia R Arends; Tamar Nijsten
Journal:  J Invest Dermatol       Date:  2013-11-27       Impact factor: 8.551

3.  A Clinical-EEG Study of Sleepiness and Psychological Symptoms in Pharmacoresistant Epilepsy Patients Treated with Lacosamide.

Authors:  Filippo S Giorgi; Chiara Pizzanelli; Veronica Pelliccia; Elisa Di Coscio; Michelangelo Maestri; Melania Guida; Elena Iacopini; Alfonso Iudice; Enrica Bonanni
Journal:  Epilepsy Res Treat       Date:  2013-09-19

4.  Who volunteers for phase I clinical trials? Influences of anxiety, social anxiety and depressive symptoms on self-selection and the reporting of adverse events.

Authors:  Luis Almeida; Todd B Kashdan; Teresa Nunes; Rui Coelho; António Albino-Teixeira; Patrício Soares-da-Silva
Journal:  Eur J Clin Pharmacol       Date:  2008-06       Impact factor: 3.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.